ERBB2 and neoplasm: Further, there were no differences between patients who converted to negative cytology and those who maintained a positive cytology in terms of sex, age, ECOG score, tumor localization, cT, cN, presence of signet ring cells, lymphovascular invasion, and HER2 status, p > 0.05.